Ron Tintner, M.D.
Internal Medicine Internship, University of Texas Health Science Center at Dallas, Southwestern Medical School, Dallas, TX
Ron Tintner, M.D. is Director of the Movement Disorders Clinic and Co-Director of the Center for Movement Disorders and Neurorehabilitation at the Methodist Hospital Neurological Institute in Houston, Texas. He received his training in internal medicine and neurology at the University of Texas Southwestern Medical School in Dallas, where he remained on the faculty from 1984 through 1994. While there, he was director of the movement disorders clinic and co-director of the Southwestern Clinic for Alzheimer’s and Related Disorders. He was in the private practice of neurology on the Monterey Peninsula of California till early 2000, and at the Parkinson’s Institute in Sunnyvale, CA through June 2000. He was on the faculty at the Baylor College of Medicine in Houston as a member of the team at the Parkinson’s Disease Center and Movement Disorders Clinic from 2000 until 2005. He joined the department of Neurology at the Methodist Neuroscience Institute in June 2005.
Dr. Tintner’s clinical and research interests include movement disorders (parkinsonism, tremor, Tourette syndrome, dystonia), motor control and cognitive function, and the neurobiology of music.
Movement disorders, Parkinson’s disease, motor control
Elble RJ, Pullman SL, Matsumoto JY, Raethjen J, Deuschl G, Tintner R; Tremor Research Group. (2006) Tremor amplitude is logarithmically related to 4- and 5-point tremor rating scales. Brain 129:2660-6.
Tintner R, Gross R, Winzer UF, Smalky KA, Jankovic J. (2005) Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial. Neurology 65:765-7.
Tintner R, Manian P, Gauthier P, Jankovic J. (2005) Pleuropulmonary fibrosis after long-term treatment with the dopamine agonist pergolide for Parkinson’s Disease. Arch Neurol 62:1290-5.
Ashour R, Tintner R, Jankovic J. (2005) Striatal deformities of the hand and foot in Parkinson’s disease. Lancet Neurol. 2005 Jul;4(7):423-31.
Ondo WG, Tintner R, Voung KD, Lai D, Ringholz G. (2005) Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson’s disease. Mov Disord 20:958-63.
Tintner R, Jankovic J. (2003) Dopamine agonists in Parkinson’s disease. Expert Opin Investig Drugs 12:1803-20.
Ondo WG, Tintner R, Thomas M, Jankovic J. (2002) Tetrabenazine treatment for Huntington’s disease-associated chorea. Clin Neuropharmacol 25:300-2.